PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsCerebral palsy
MeSH D002547 - cerebral palsy
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001925:Chronic brain damage
0 Companies
0 Drugs
Success rate
D002547: 
Cerebral palsy
35 Companies
2 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaBaclofen Baclofen  1988-07-21   
MylanBaclofen Baclofen  2005-07-29   
NovartisBaclofen Lioresal  1982-01-01   
UCBBaclofen Kemstro  2003-10-30   
Aurobindo PharmaBaclofen Baclofen  2021-07-13   
Zydus TherapeuticsBaclofen Baclofen  2018-11-23   
Sun Pharmaceutical IndustriesBaclofen Baclofen  2006-08-14   
Amneal PharmaceuticalsBaclofen Baclofen  2016-05-03   
Baclofen Lioresal  1992-06-17   
Baclofen Lyvispah 2039-07-29 2021-11-22   
LannettBaclofen Baclofen  2005-12-20   
Impax LaboratoriesBaclofen Baclofen  2007-10-26   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
71%
10/14
Phase 2
92%
12/13
Phase 3
23%
6/26
Approved: 2Overall Success rate: 15%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Dutetrabenazine
Mylan
Baclofen
Novartis
Baclofen
UCB
Baclofen
Impax Laboratories
Baclofen
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use